Needle-free peptides.Your brand. Our gels.
Leading supplier of high quality gel-based peptides to US telehealth companies
Made in a 503A and an FDA-registered 503B facility.
What is Geltides?
Who we supplyWe make needle-free peptide gels and supply them to US telehealth, under your brand or ours.
- Telehealth platformsLongevity clinicsDiagnostics platformsPerformance medicineMen’s healthWomen’s health
- From $35 / unitAvailable nowNAD+GT 101-CCobalt · Cellular energy
- From $35 / unitAvailable nowGHK-CuGT 201-CCopper · Skin and hair
- From $35 / unitAvailable nowGlow BlendGT 202-CBlush · Skin and hair
- From $35 / unitJoin waitlistKlowGT 203-CRosewood · Skin and hair
- From $35 / unitJoin waitlistWolverineGT 301-CIron Red · Recovery
- From $35 / unitJoin waitlistTesamorelinGT 401-CAmber · GH and body composition
- From $35 / unitJoin waitlistIpamorelinGT 402-CHoney · GH and body composition
- From $35 / unitJoin waitlistMOTS-cGT 501-CMito Lime · Metabolic
The colour system
Every peptide gets a code and a colour. The hue marks its family, the shade marks the product. Built to scale from 8 launch SKUs to a 7,000-strong library.
- 1XXCellular energy
- 2XXSkin and hair
- 3XXRecovery
- 4XXGH and body composition
- 5XXMetabolic
- 6XXCognition and sleep
- 7XXSexual health
- 8XXImmune
No more injecting. Just a gel under the tongue.
A simple daily dose that patients are happy to take, and that opens your peptide programme to everyone, including people who would never self-inject.
- 01
No needles
A measured dose under the tongue. No syringes, no injection training, no sharps.
- 02
No reconstitution
Ready to use. No bacteriostatic water, no dosing maths, no mixing errors.
- 03
Mucosal route
Designed to sidestep gut degradation and first-pass metabolism.
- 04
Clean formulation
GRAS-status ingredients in a no-heat process that protects the peptide.
A gel matrix engineered for the oral mucosa.
The gel holds peptides against the mucosa under the tongue and inside the cheek, a route to the bloodstream designed to sidestep gut degradation and first-pass metabolism. GRAS-status ingredients, made in a no-heat process.
Early-stage data. Full summaries under NDA.Your brand, or our brand
01 · Private label
MOST PARTNERSYour name, colours and packaging on our formulations. Patients only ever see you.
- Packaging
- YOUR BRAND
- SKUs
- ANY FROM THE RANGE
- Minimum order
- 5,000 / SKU
- First batch
- [X] WEEKS
02 · Geltides label
A finished, patient-ready brand for your platform. The fastest way to test demand before committing to your own label.
- Packaging
- GELTIDES OR CO-BRANDED
- Minimum order
- 5,000 / SKU
- Patient content
- INCLUDED
- Upgrade path
- PRIVATE LABEL ANYTIME
- 01
Choose your SKUs
Pricing, study summaries and samples under NDA.
- 02
Brand it
We produce dispenser, carton and insert for your sign-off.
- 03
Connect fulfilment
Bulk office-use supply from the 503B, or patient-specific prescriptions dispensed by the 503A.
- 04
Launch and reorder
Batch release with a COA. Reorder on a set cycle.
Built for the diligence your clinical and legal teams will run.
Made in a state-licensed 503A pharmacy and an FDA-registered 503B outsourcing facility. The 503B operates under cGMP. Backed by a pharmaceutical supply group operating since 1999 [CONFIRM]. Every claim below comes with a document you can request.
- ACTIVEState-licensed 503A pharmacyLicence [#######] · [N] states
- ACTIVEFDA-registered 503BFEI [##########]
- ACTIVE503B cGMP manufacturingLast inspection [DATE]
- ACTIVEISO 17025 lab COAsLab: [LAB NAME]
- PENDINGLegitScript certifiedID [#######]
- PENDINGPatent pendingApplication [NUMBER]
- ACTIVEProduct liabilityCover $[X]M
- ACTIVEHIPAA BAAAvailable on request
- PENDINGUK MHRA licenceExpected Q2 2027
Six gates before any supply commitment
NO SHORTCUTS ON MANUFACTURER, CUSTOMS, LICENSING OR SANCTIONS CONTROLS- 01CounterpartyLegal entities, ownership and sanctions screening confirmed.
- 02ProductSKU identity, status and permitted route to market confirmed.
- 03QualitySamples matched to batch records and COA documentation.
- 04RouteStorage, shipping and chain-of-custody requirements validated.
- 05CommercialPricing, payment terms and contracting structure agreed.
- 06ContractSigned only after legal, tax and regulatory review.
- Independent tissue modelsPermeation and safety tested on reconstructed human tissue (MatTek).
- No tissue damageNo structural damage or morphology changes across multiple compounds tested.
- Randomised controlled designA randomised, double-blind, placebo-controlled study on the platform, with no adverse effects reported.
- Clean human safety recordNo adverse effects reported in human studies to date. Observational peptide data is available to partners under NDA.
"[Quote from partner on launching a needle-free peptide line with Geltides.]"
[Name], [Role], [Partner]- [X]%
- PATIENT ADHERENCE VS INJECTABLES
- [X] WKS
- NDA TO FIRST PATIENT
- [X]
- PATIENTS IN PILOT
- [X]%
- REORDER RATE
The people behind Geltides
- Patrick [Surname]CO-FOUNDER[Short bio: background, previous companies, why Geltides.]GELTIDES TEAM01
- [Name], MDMEDICAL ADVISOR · [SPECIALTY]Board-certified in [specialty]. [Institution].MEDICAL ADVISORY BOARD02
- [Name], PharmDPHARMACY ADVISOR · 503A / 503B[Years] in sterile and non-sterile compounding. [Institution].MEDICAL ADVISORY BOARD03
- [Name], PhDSCIENTIFIC ADVISOR · PEPTIDES[Research focus]. [Institution].MEDICAL ADVISORY BOARD04
Talk to sales
Product sheet, wholesale pricing, study summaries and samples. Shared under mutual NDA. Reply within one business day.
partners@geltides.com